Sign in
4

Changes in Ownership

Rapport Therapeutics, Inc. Filed Acc 0001193125-26-430504

Chief Executive Officer sold 2,210 shares at $29.16 ($64,448)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ceesay Abraham Chief Executive Officer 2026-10-21 Sale 10b5-1 −2,210 $29.16 $64,448 450,035 D: show line 1 in the form
Open-market sales · 2,210 sh · avg $29.16 · $64,448
Loading xslF345X06/ownership.xml…